COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02628574
Brief Title: Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab

First Submitted : December 1, 2015
First Submitted that Met QC Criteria : December 9, 2015
First Posted : December 11, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 24, 2019
Last Update Posted : September 25, 2019